Drugs that affect lipid metabolism

Sharobeem, 2000, Acute renal failure after cardiopulmonary bypass: a possible association with drugs of the fibrate group, J Cardiovasc Pharmacol Ther, 5, 33, 10.1177/107424840000500105 Negvesky, 2000, Reversible atorvastatin-associated external ophthalmoplagia, anti-acetylcholine receptor antibodies, and ataxia, Arch Ophthalmol, 118, 427 Farmer, 2000, Comparative tolerability of the HMG-CoA reductase inhibitors, Drug Saf, 23, 197, 10.2165/00002018-200023030-00003 Muldoon, 2000, Effects of lovastatin on cognitive function and psychological well-being, Am J Med, 108, 538, 10.1016/S0002-9343(00)00353-3 Belaiche, 2000, Pancreatite aiguë associée a, la prise d'atorvastatine, Gastroenterol Clin Biol, 24, 471 Pershad, 1999, Simvastatin and rhabdomyolysis — a case report and brief review, J Pharm Technol, 15, 88, 10.1177/875512259901500305 Al Shohaib, 2000, Simvastatin-induced rhabdomyolysis in a patient with chronic renal, failure, Am J Nephrol, 20, 212, 10.1159/000013589 Insull, 2000, Efficacy and safety of cerivastatin 0.8 mg in patients with hypercholesterolaemia: the pivotal placebo-controlled clinical trial, J Int Med Res, 28, 47, 10.1177/147323000002800201 Rodriguez, 2000, Cerivastatin-induced rhabdomyolysis, Ann Intern Med, 132, 598, 10.7326/0003-4819-132-7-200004040-00031 Pogson, 1999, Rhabdomyolysis and renal failure associated with cerivastatin-gemfibrozil combination therapy, Am J Cardiol, 83, 1146, 10.1016/S0002-9149(99)00034-X Plosker, 2000, Cerivastatin: a review of its pharmacological properties and therapeutic efficacy in the management of hypercholesterolaemia, Drugs, 60, 1179, 10.2165/00003495-200060050-00011 Horsmans, 1999, Differential metabolism of statins: importance in drug-drug interactions, Eur Heart J Suppl, 1, T7 Muck, 1999, Increase in cerivastatin systemic exposure after single and multiple dosing in cyclosporine-treated kidney transplant recipients, Clin Pharmacol Ther, 65, 251, 10.1016/S0009-9236(99)70104-9 Masica, 2000, Intravenous diltiazem and CYP3A-mediated metabolism, Br J Clin Pharmacol, 50, 273, 10.1046/j.1365-2125.2000.00249.x Spieker, 2000, Efficacy and tolerability of fluvastatin and bezafibrate in patients with hyperlipidemia and persistently high triglyceride levels, J Cardiovasc Pharmacol, 35, 361, 10.1097/00005344-200003000-00003 Bermingham, 2000, Rhabdomyolysis in a patient receiving the combination of cerivastatin and gemfibrozil, Am J Health-Syst Pharm, 57, 461, 10.1093/ajhp/57.5.461 Özdemir, 2000, A case with severe rhabdomyolysis and renal failure associated with cerivastatingemfibrozil combination therapy: a case report, Angiology, 51, 695 Alexandridis, 2000, Rhabdomyolysis due to combination therapy with cerivastatin and gemfibrozil, Am J Med, 109, 261, 10.1016/S0002-9343(00)00514-3 Plotkin, 2000, Influenza vaccine — a possible trigger of rhabdomyolysis induced acute renal failure due to the combined use of cerivastatin and bezafibrate, Nephrol Dial Transplant, 15, 740, 10.1093/ndt/15.5.740 Backman, 2000, Plasma concentrations of active simvastatin acid are increased by gemfibrozil, Clin Pharmacol Ther, 68, 122, 10.1067/mcp.2000.108507 Lilja, 2000, Duration of effect of grapefruit juice on the pharmacokinetics of the CYP3A4 substrate simvastatin, Clin Pharmacol Ther, 68, 384, 10.1067/mcp.2000.110216 Kantola, 2000, Effect of fluconazole on plasma fluvastatin and pravastatin concentrations, Eur J Clin Pharmacol, 56, 225, 10.1007/s002280000127 Mazzu, 2000, Itraconazole alters the pharmacokinetics of atorvastatin to a greater extent than either cerivastatin or pravastatin, Clin Pharmacol Ther, 68, 391, 10.1067/mcp.2000.110537 Kyrklund, 2000, Rifampin greatly reduces plasma simvastatin and simvastatin acid concentrations, Clin Pharmacol Ther, 68, 592, 10.1067/mcp.2000.111414 DiTusa, 2000, Potential interaction between troglitazone and atorvastatin, J Clin Pharm Ther, 25, 279, 10.1046/j.1365-2710.2000.00288.x Yeshurun, 2000, Acipimox as a secondary hypolipidemia in combined hypertriglyceridemia and hyperlipidemia, Harefuah, 138, 650